Jonathan G Drachman - Net Worth and Insider Trading
Jonathan G Drachman Net Worth
The estimated net worth of Jonathan G Drachman is at least $40 Million dollars as of 2024-04-25. Jonathan G Drachman is the CMO & EVP, R & D of Seagen Inc and owns about 170,934 shares of Seagen Inc (SGEN) stock worth over $39 Million. Jonathan G Drachman is the President and CEO of Neoleukin Therapeutics Inc and owns about 119,934 shares of Neoleukin Therapeutics Inc (NLTX) stock worth over $418,570. Jonathan G Drachman is also the Director of Calithera Biosciences Inc and owns about 10,000 shares of Calithera Biosciences Inc (CALA) stock worth over $200. Details can be seen in Jonathan G Drachman's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Jonathan G Drachman has not made any transactions after 2021-11-10 and currently still holds the listed stock(s).
Transaction Summary of Jonathan G Drachman
Jonathan G Drachman Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Jonathan G Drachman owns 4 companies in total, including Neoleukin Therapeutics Inc (NLTX) , Calithera Biosciences Inc (CALA) , and Harpoon Therapeutics Inc (HARP) among others .
Click here to see the complete history of Jonathan G Drachman’s form 4 insider trades.
Insider Ownership Summary of Jonathan G Drachman
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| NLTX | Neoleukin Therapeutics Inc | 2021-08-25 | director & See Remarks |
| CALA | Calithera Biosciences Inc | 2021-11-10 | director |
| HARP | Harpoon Therapeutics Inc | 2019-02-07 | director |
| SGEN | Seagen Inc | 2018-03-20 | See Remarks |
Jonathan G Drachman Latest Holdings Summary
Jonathan G Drachman currently owns a total of 3 stocks. Among these stocks, Jonathan G Drachman owns 170,934 shares of Seagen Inc (SGEN) as of March 5, 2018, with a value of $39 Million and a weighting of 98.94%. Jonathan G Drachman owns 119,934 shares of Neoleukin Therapeutics Inc (NLTX) as of August 25, 2021, with a value of $418,570 and a weighting of 1.06%. Jonathan G Drachman also owns 10,000 shares of Calithera Biosciences Inc (CALA) as of November 10, 2021, with a value of $200 and a weighting of 0%.
Latest Holdings of Jonathan G Drachman
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SGEN | Seagen Inc | 2018-03-05 | 170,934 | 228.74 | 39,099,443 |
| NLTX | Neoleukin Therapeutics Inc | 2021-08-25 | 119,934 | 3.49 | 418,570 |
| CALA | Calithera Biosciences Inc | 2021-11-10 | 10,000 | 0.02 | 200 |
Holding Weightings of Jonathan G Drachman
Jonathan G Drachman Form 4 Trading Tracker
According to the SEC Form 4 filings, Jonathan G Drachman has made a total of 0 transactions in Seagen Inc (SGEN) over the past 5 years. The most-recent trade in Seagen Inc is the sale of 10,457 shares on March 5, 2018, which brought Jonathan G Drachman around $552,443.
According to the SEC Form 4 filings, Jonathan G Drachman has made a total of 2 transactions in Neoleukin Therapeutics Inc (NLTX) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Neoleukin Therapeutics Inc is the acquisition of 7,500 shares on August 25, 2021, which cost Jonathan G Drachman around $933,000.
According to the SEC Form 4 filings, Jonathan G Drachman has made a total of 1 transactions in Calithera Biosciences Inc (CALA) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Calithera Biosciences Inc is the acquisition of 10,000 shares on November 10, 2021, which cost Jonathan G Drachman around $172,000.
Insider Trading History of Jonathan G Drachman
- 1
Jonathan G Drachman Trading Performance
GuruFocus tracks the stock performance after each of Jonathan G Drachman's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Jonathan G Drachman is -27.93%. GuruFocus also compares Jonathan G Drachman's trading performance to market benchmark return within the same time period. The performance of stocks bought by Jonathan G Drachman within 3 months outperforms 1 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Jonathan G Drachman's insider trading performs compared to the benchmark.
Performance of Jonathan G Drachman
Average Return
-52.88%
Outperforming Transactions
33%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 1.64 | -27.93 | -25.02 | -52.88 | -64.76 | -65.61 |
| Relative Return to S&P 500(%) | 0.35 | -18.95 | -18.28 | -50.77 | -69.94 | -71.47 |
Jonathan G Drachman Ownership Network
Ownership Network List of Jonathan G Drachman
Ownership Network Relation of Jonathan G Drachman
Jonathan G Drachman Owned Company Details
What does Neoleukin Therapeutics Inc do?
Who are the key executives at Neoleukin Therapeutics Inc?
Jonathan G Drachman is the director & See Remarks of Neoleukin Therapeutics Inc. Other key executives at Neoleukin Therapeutics Inc include 10 percent owner Baker Bros. Advisors Lp , Principal Accounting Officer Sean Michael Smith , and Chief Medical Officer Priti Patel .
Neoleukin Therapeutics Inc (NLTX) Insider Trades Summary
Over the past 18 months, Jonathan G Drachman made no insider transaction in Neoleukin Therapeutics Inc (NLTX). Other recent insider transactions involving Neoleukin Therapeutics Inc (NLTX) include a net sale of 18,149 shares made by Priti Patel , a net sale of 4,639 shares made by Sean Michael Smith , and a net purchase of 2,285,342 shares made by Baker Bros. Advisors Lp .
In summary, during the past 3 months, insiders sold 0 shares of Neoleukin Therapeutics Inc (NLTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 1,139 shares of Neoleukin Therapeutics Inc (NLTX) were sold and 114,267 shares were bought by its insiders, resulting in a net purchase of 113,128 shares.
Neoleukin Therapeutics Inc (NLTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Neoleukin Therapeutics Inc Insider Transactions
Jonathan G Drachman Mailing Address
Above is the net worth, insider trading, and ownership report for Jonathan G Drachman. You might contact Jonathan G Drachman via mailing address: 21823 30th Drive Se, Bothell Wa 98021.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
